Janus Henderson Group PLC Corcept Therapeutics Inc Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 104,720 shares of CORT stock, worth $7.57 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
104,720
Previous 246,839
57.58%
Holding current value
$7.57 Million
Previous $28.2 Million
72.74%
% of portfolio
0.0%
Previous 0.02%
Shares
26 transactions
Others Institutions Holding CORT
# of Institutions
479Shares Held
83.4MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.2 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$700 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$558 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$453 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$280 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.74B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...